Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Experimental Neurology

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2016.03.024PMID 27072528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats

  2014cited by this paper
• Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance

  2014cited by this paper
• Adaptive gene expression changes on the healthy side of parkinsonian rats.

  2013cited by this paper
• Locomotor Velocity and Striatal Adaptive Gene Expression Changes of the Direct and Indirect Pathways in Parkinsonian Rats

  2013cited by this paper
• Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease

  2012cited by this paper
• Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.

  2010cited by this paper
• Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia.

  2009cited by this paper
• Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia

  2009cited by this paper
• Chronic intermittent L‐DOPA treatment induces changes in dopamine release

  2009cited by this paper
• Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in l-DOPA-Induced Dyskinesia

  2007cited by this paper
• Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

  2007cited by this paper
• Ratings of L‐DOPA‐Induced Dyskinesia in the Unilateral 6‐OHDA Lesion Model of Parkinson's Disease in Rats and Mice

  2007cited by this paper
• Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia.

  2007cited by this paper
• Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.

  2007cited by this paper
• Role of striatal l‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats

  2006cited by this paper
• Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia

  2005cited by this paper
• Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.

  2004cited by this paper
• L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

  2002cited by this paper
• Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

  2002cited by this paper
• Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.

  2001cited by this paper
• Persistent changes in striatal gene expression induced by long‐term l‐DOPA treatment in a rat model of Parkinson's disease

  2001cited by this paper
• Adenosine A2A receptor gene expression in the normal striatum and after 6-OH-dopamine lesion

  2000cited by this paper
• Alterations in preproenkephalin and adenosine‐2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l‐DOPA

  2000cited by this paper
• Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.

  1999cited by this paper
• Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

  1999cited by this paper
• Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.

  1999cited by this paper
• L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐ and glutamic acid decarboxylase mRNA

  1998cited by this paper
• Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat.

  1998cited by this paper
• Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease.

  1997cited by this paper
• Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.

  1997cited by this paper
• The basal ganglia and adaptive motor control.

  1994cited by this paper
• Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.

  1992cited by this paper
• Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis

  1991cited by this paper
• Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation.

  1990cited by this paper
• D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

  1990cited by this paper
• Motor functions of the striatum in the rat: critical role of the lateral region in tongue and forelimb reaching.

  1988cited by this paper
• Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study.

  1988cited by this paper
• Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.

  1986influential reference
• Sequence and expression of the rat prodynorphin gene.

  1985cited by this paper
• Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing.

  1985cited by this paper
• Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system.

  1984influential reference
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Evidence for a long Leu-enkephalin striopallidal pathway in rat brain

  1978cited by this paper
• The synaptic organization of the caudate nucleus.

  1971cited by this paper

• Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

  2025cites this paper
• Preserving Neuronal Chemical Messengers: Heat Stabilization Versus Snap Freezing for Improved MALDI Mass Spectrometry Imaging of Brain Tissues

  2025cites this paper
• Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model.

  2024cites this paper
• Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: a use case studying depression as a risk factor for Alzheimer’s disease

  2023cites this paper
• Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion

  2023influential citation
• Genome‐Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India

  2022cites this paper
• Interactive Responses of Enkephalin, δ-opioid Receptor and Dopamine Receptor D1/D2 to Hypoxia and/or MPP+ Stress in PC12 Cells

  2021cites this paper
• Neuropeptides and Behaviors: How Small Peptides Regulate Nervous System Function and Behavioral Outputs

  2021cites this paper
• Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.

  2020cites this paper
• Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy.

  2020cites this paper
• The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia

  2020influential citation
• Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced Dyskinesias

  2019cites this paper
• Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia.

  2019cites this paper
• Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson’s Disease

  2019cites this paper
• Enkephalins and ACTH in the mammalian nervous system.

  2019cites this paper
• The combination of the opioid glycopeptide MMP‐2200 and a NMDA receptor antagonist reduced l‐DOPA‐induced dyskinesia and MMP‐2200 by itself reduced dopamine receptor 2‐like agonist‐induced dyskinesia

  2018influential citation
• Diverse serotonin actions of vilazodone reduce l‐3,4‐dihidroxyphenylalanine–induced dyskinesia in hemi‐parkinsonian rats

  2018cites this paper
• Selegiline increases on time without exacerbation of dyskinesia in 6‐hydroxydopamine‐lesioned rats displaying l‐Dopa‐induced wearing‐off and abnormal involuntary movements

  2018cites this paper
• Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia

  2018influential citation
• Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson’s Disease Differently Affects Behavior

  2017cites this paper
• Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum

  2017influential citation
• Usporedba pentadekapeptida BPC 157 i Rac 1 inhibitora

  2016cites this paper